Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 421
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06143423 | A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects. | ||
| NCT05610202 | Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects | ||
| NCT06031480 | Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors | ||
| NCT05959694 | A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) . | ||
| NCT04207463 | A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors | ||
| NCT07037238 | An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations | ||
| NCT05982106 | To Evaluate the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult Subjects | ||
| NCT05646758 | A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects | ||
| NCT06010537 | Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle | ||
| NCT06218771 | A Study of TQB3454 Tablets in Patients With Blood Tumors | ||
| NCT02752516 | A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics | ||
| NCT05306847 | Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer | ||
| NCT06873854 | A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours | ||
| NCT04236362 | A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer | ||
| NCT05780567 | Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer | ||
| NCT07291050 | A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant Tumors | ||
| NCT05975645 | A Clinical Study of TQB2618 Injection Combined With Penpulimab Injection and Anlotinib Hydrochloride Capsules for First-line Treatment of Advanced Hepatocellular Carcinoma (HCC). | ||
| NCT06448273 | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects | ||
| NCT04063683 | Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）. | ||
| NCT01846650 | A Bioequivalence Study of Capecitabine Tablets | ||
| NCT07165951 | Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) | ||
| NCT02649361 | Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102) | ||
| NCT06202261 | A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast Cancer | ||
| NCT04805060 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors | ||
| NCT04853498 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets | ||
| NCT05193604 | A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | ||
| NCT04574284 | A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer | ||
| NCT06644417 | Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection | ||
| NCT03766490 | Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer | ||
| NCT05815862 | Clinical Study of AL2846 Capsules in the Treatment of Advanced Lung Tumor and Advanced Ovarian Cancer | ||
| NCT04337879 | A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer | ||
| NCT05405439 | To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer | ||
| NCT05340530 | To Evaluate the Pharmacokinetic Effects of TQD3606 for Injection in Healthy Adult Subjects | ||
| NCT03799601 | Docetaxel Combined With Carboplatin Plus Anlotinib as First Line Treatment in NSCLC | ||
| NCT05107037 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis | ||
| NCT06122831 | A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF) | ||
| NCT05051930 | A Clinical Trial of TQC3721 Suspension for Inhalation | ||
| NCT05830500 | Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma | ||
| NCT05284994 | TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer | ||
| NCT03460457 | Tolerance and Pharmacokinetics of TQB2450 | ||
| NCT05346952 | A Study of TQB2450 Injection Plus Chemotherapy Followed by TQB2450 Plus Anlotinib Versus Tislelizumab Plus Chemotherapy Followed by Tislelizumab in the Treatment of First-line Non-squamous Non-small Cell Lung Cancer(NSCLC). | ||
| NCT07266116 | Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients | ||
| NCT05020652 | A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis | ||
| NCT04202653 | Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study) | ||
| NCT06160895 | A Clinical Trial of TQ-A3334 Tablet After Multiple Administration in Adult Subjects | ||
| NCT04278820 | A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC) | ||
| NCT05494060 | XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma | ||
| NCT05292196 | A Phase II Clinical Trial of TQC3721 Suspension for Inhalation | ||
| NCT06431490 | A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer | ||
| NCT07294261 | Garsorasib In KRAS G12C Mutant Locally Advanced and Metastatic NSCLC |
